Forbes December 15, 2023
John LaMattina

For over 100 years, the U.S. has believed that investments in basic research were important for the public good – for our defense, for our health and for our economic prosperity. Furthermore, for these investments to be of value, any progress has to be broadly disseminated and made available so that it can contribute to the common good. Back in 1980, Congress was concerned about U.S. industry competitiveness believing that intellectual property being generated by government funds was not being utilized. This led to the passage of the Bayh-Dole Act which enabled small companies and universities to retain title to inventions made under federally funded research programs. This was instrumental in encouraging universities to participate in technology transfer activities thereby...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Sun Pharma buys Checkpoint and its new cancer drug
3 ways to accelerate development and de-risk cell and gene therapy manufacturing
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
CVS Plans Chain of Smaller-Footprint Pharmacy-Focused Stores
As Walgreens Preps For New Owner, CVS Health Tries Smaller Drugstores

Share This Article